Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
2 recherche sur le mot-clé 'age variation'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Age-Related Variation in Health Service Use and Associated Expenditures Among Children with Autism / Zuleyha CIDAV in Journal of Autism and Developmental Disorders, 43-4 (April 2013)
[article]
Titre : Age-Related Variation in Health Service Use and Associated Expenditures Among Children with Autism Type de document : Texte imprimé et/ou numérique Auteurs : Zuleyha CIDAV, Auteur ; Lindsay LAWER, Auteur ; Steven C. MARCUS, Auteur ; David S. MANDELL, Auteur Article en page(s) : p.924-931 Langues : Anglais (eng) Mots-clés : Autism Economics Cost Expenditures Utilization Medicaid Age variation Index. décimale : PER Périodiques Résumé : This study examined differences by age in service use and associated expenditures during 2005 for Medicaid-enrolled children with autism spectrum disorders. Aging was associated with significantly higher use and costs for restrictive, institution-based care and lower use and costs for community-based therapeutic services. Total expenditures increased by 5 % with each year of age; by 23 % between 3–5 and 6–11 year olds, 23 % between 6–11 and 12–16, and 14 % between 12–16 and 17–20 year olds. Use of and expenditures for long-term care, psychiatric medications, case management, medication management, day treatment/partial hospitalization, and respite services increased with age; use of and expenditures for occupational/physical therapy, speech therapy, mental health services, diagnostic/assessment services, and family therapy declined. En ligne : http://dx.doi.org/10.1007/s10803-012-1637-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=194
in Journal of Autism and Developmental Disorders > 43-4 (April 2013) . - p.924-931[article] Age-Related Variation in Health Service Use and Associated Expenditures Among Children with Autism [Texte imprimé et/ou numérique] / Zuleyha CIDAV, Auteur ; Lindsay LAWER, Auteur ; Steven C. MARCUS, Auteur ; David S. MANDELL, Auteur . - p.924-931.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 43-4 (April 2013) . - p.924-931
Mots-clés : Autism Economics Cost Expenditures Utilization Medicaid Age variation Index. décimale : PER Périodiques Résumé : This study examined differences by age in service use and associated expenditures during 2005 for Medicaid-enrolled children with autism spectrum disorders. Aging was associated with significantly higher use and costs for restrictive, institution-based care and lower use and costs for community-based therapeutic services. Total expenditures increased by 5 % with each year of age; by 23 % between 3–5 and 6–11 year olds, 23 % between 6–11 and 12–16, and 14 % between 12–16 and 17–20 year olds. Use of and expenditures for long-term care, psychiatric medications, case management, medication management, day treatment/partial hospitalization, and respite services increased with age; use of and expenditures for occupational/physical therapy, speech therapy, mental health services, diagnostic/assessment services, and family therapy declined. En ligne : http://dx.doi.org/10.1007/s10803-012-1637-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=194 Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study / C. CROTEAU in Autism, 23-8 (November 2019)
[article]
Titre : Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study Type de document : Texte imprimé et/ou numérique Auteurs : C. CROTEAU, Auteur ; Laurent MOTTRON, Auteur ; M. DORAIS, Auteur ; J. E. TARRIDE, Auteur ; S. PERREAULT, Auteur Article en page(s) : p.2020-2030 Langues : Anglais (eng) Mots-clés : age variation autism spectrum disorder economic costs health services healthcare utilization interventions-pharmacologic predictors psychiatric costs psychoactive drugs Index. décimale : PER Périodiques Résumé : A number of cross-sectional studies report extensive use of psychiatric services and high healthcare costs in autistic youths. However, little is known about how the use of these services evolves from the time of diagnosis, as children grow up. Our objectives were to investigate the use, costs, and predictors of psychiatric services following autism spectrum diagnosis. We built a cohort of 1227 newly diagnosed autism spectrum individuals identified in the Quebec (Canada) Regie de l'assurance maladie du Quebec administrative database (January 1998 to December 2010). Mean number and cost per individual of psychiatric healthcare use (hospitalizations, medical visits, psychoactive drug use) were calculated yearly for 5 years following autism spectrum diagnosis. Mean number of psychiatric visits decreased over time by more than threefold (7.5 vs 2.1 visits) from year 1 to year 5, whereas psychoactive drug use increased from 16.0 to 25.2 claims. Psychiatric hospitalizations decreased during follow-up, but still represented the greatest costs per individual (CAD9820 for year 1; CAD4628 for year 5). Antipsychotics represented over 50% of drug costs. Mixed-effect model with repeated measures showed that previous psychoactive drug use was the strongest predictor of greater psychiatric healthcare cost during follow-up (odds ratio: 9.96; 95% confidence interval: 7.58-13.10). These trends contrast with guidelines advocating cautious prescribing of antipsychotics with periodical re-assessment of their benefit. En ligne : http://dx.doi.org/10.1177/1362361319840229 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=407
in Autism > 23-8 (November 2019) . - p.2020-2030[article] Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study [Texte imprimé et/ou numérique] / C. CROTEAU, Auteur ; Laurent MOTTRON, Auteur ; M. DORAIS, Auteur ; J. E. TARRIDE, Auteur ; S. PERREAULT, Auteur . - p.2020-2030.
Langues : Anglais (eng)
in Autism > 23-8 (November 2019) . - p.2020-2030
Mots-clés : age variation autism spectrum disorder economic costs health services healthcare utilization interventions-pharmacologic predictors psychiatric costs psychoactive drugs Index. décimale : PER Périodiques Résumé : A number of cross-sectional studies report extensive use of psychiatric services and high healthcare costs in autistic youths. However, little is known about how the use of these services evolves from the time of diagnosis, as children grow up. Our objectives were to investigate the use, costs, and predictors of psychiatric services following autism spectrum diagnosis. We built a cohort of 1227 newly diagnosed autism spectrum individuals identified in the Quebec (Canada) Regie de l'assurance maladie du Quebec administrative database (January 1998 to December 2010). Mean number and cost per individual of psychiatric healthcare use (hospitalizations, medical visits, psychoactive drug use) were calculated yearly for 5 years following autism spectrum diagnosis. Mean number of psychiatric visits decreased over time by more than threefold (7.5 vs 2.1 visits) from year 1 to year 5, whereas psychoactive drug use increased from 16.0 to 25.2 claims. Psychiatric hospitalizations decreased during follow-up, but still represented the greatest costs per individual (CAD9820 for year 1; CAD4628 for year 5). Antipsychotics represented over 50% of drug costs. Mixed-effect model with repeated measures showed that previous psychoactive drug use was the strongest predictor of greater psychiatric healthcare cost during follow-up (odds ratio: 9.96; 95% confidence interval: 7.58-13.10). These trends contrast with guidelines advocating cautious prescribing of antipsychotics with periodical re-assessment of their benefit. En ligne : http://dx.doi.org/10.1177/1362361319840229 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=407